Till sidinnehåll


Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., . . . et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85(5), 365-376.

Abbas, G., & Lindor, K. D. (2009). Cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Cancer, 40(1-2), 19-25. doi:10.1007/s12029-009-9085-8

Abbas, S., & Sandroussi, C. (2013). Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford), 15(7), 492-503. doi:10.1111/j.1477-2574.2012.00616.x

Abdalla, E. K., Adam, R., Bilchik, A. J., Jaeck, D., Vauthey, J. N., & Mahvi, D. (2006). Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol, 13(10), 1271-1280. doi:10.1245/s10434-006-9045-5

Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. Retrieved from https://www.clinicaltrials.gov/ct2/show/NCT01073839?term=cholangiocarcinoma+adjuvant&rank=3

Adler, D., Schmidt, C. M., Al-Haddad, M., Barthel, J. S., Ljung, B. M., Merchant, N. B., . . . Layfield, L. J. (2014). Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines. Cytojournal, 11(Suppl 1), 1. doi:10.4103/1742-6413.133326

Agarwal, A. K., Kalayarasan, R., Javed, A., Gupta, N., & Nag, H. H. (2013). The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer. Ann Surg, 258(2), 318-323. doi:10.1097/SLA.0b013e318271497e

Aitken, K. L., & Hawkins, M. A. (2014). The role of radiotherapy and chemoradiation in the management of primary liver tumours. Clin Oncol (R Coll Radiol), 26(9), 569-580. doi:10.1016/j.clon.2014.05.016

AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group., (2011.

Albores-Saavedra, J., Batich, K., Hossain, S., Henson, D. E., & Schwartz, A. M. (2009). Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Ann Diagn Pathol, 13(6), 378-383. doi:10.1016/j.anndiagpath.2009.08.002

Albores-Saavedra, J., Keenportz, B., Bejarano, P. A., Alexander, A. A., & Henson, D. E. (2007). Adenomyomatous hyperplasia of the gallbladder with perineural invasion: revisited. Am J Surg Pathol, 31(10), 1598-1604. doi:10.1097/PAS.0b013e31804fa10e

Alessiani, M., Tzakis, A., Todo, S., Demetris, A. J., Fung, J. J., & Starzl, T. E. (1995). Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg, 180(1), 1-9.

Alkhawaldeh, K., Faltten, S., Biersack, H. J., & Ezziddin, S. (2011). The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis. Clin Nucl Med, 36(10), 879-883. doi:10.1097/RLU.0b013e3182291a64

Andre, T., Tournigand, C., Rosmorduc, O., Provent, S., Maindrault-Goebel, F., Avenin, D., . . . Group, G. (2004). Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol, 15(9), 1339-1343. doi:10.1093/annonc/mdh351

Araida, T., Higuchi, R., Hamano, M., Kodera, Y., Takeshita, N., Ota, T., . . . Takasaki, K. (2009a). Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey--a multicenter study. J Hepatobiliary Pancreat Surg, 16(2), 204-215. doi:10.1007/s00534-009-0044-3

Araida, T., Higuchi, R., Hamano, M., Kodera, Y., Takeshita, N., Ota, T., . . . Takasaki, K. (2009b). Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today, 39(9), 770-779. doi:10.1007/s00595-009-3960-6

Araida, T., Yoshikawa, T., Azuma, T., Ota, T., Takasaki, K., & Hanyu, F. (2004). Indications for pancreatoduodenectomy in patients undergoing lymphadenectomy for advanced gallbladder carcinoma. J Hepatobiliary Pancreat Surg, 11(1), 45-49. doi:10.1007/s00534-003-0867-2

Aramaki, M., Matsumoto, T., Shibata, K., Himeno, Y., Yada, K., Hirano, S., . . . Kitano, S. (2004). Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma. Hepatogastroenterology, 51(60), 1609-1611.

Asayama, Y., Yoshimitsu, K., Irie, H., Tajima, T., Nishie, A., Hirakawa, M., . . . Honda, H. (2006). Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology, 238(1), 150-155. doi:10.1148/radiol.2381041765

Ayuso, J. R., Pages, M., & Darnell, A. (2013). Imaging bile duct tumors: staging. Abdom Imaging, 38(5), 1071-1081. doi:10.1007/s00261-013-0021-9

Baer, H. U., Matthews, J. B., Schweizer, W. P., Gertsch, P., & Blumgart, L. H. (1990). Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula. Br J Surg, 77(7), 743-745.

Balachandran, P., Agarwal, S., Krishnani, N., Pandey, C. M., Kumar, A., Sikora, S. S., . . . Kapoor, V. K. (2006). Predictors of long-term survival in patients with gallbladder cancer. J Gastrointest Surg, 10(6), 848-854. doi:10.1016/j.gassur.2005.12.002

Beltran, M. A., Csendes, A., & Cruces, K. S. (2008). The relationship of Mirizzi syndrome and cholecystoenteric fistula: validation of a modified classification. World J Surg, 32(10), 2237-2243. doi:10.1007/s00268-008-9660-3

Benkel, I., Wijk, H., & Molander, U. (2012). Loved ones obtain various information about the progression of the patient's cancer disease which is important for their understanding and preparation. Am J Hosp Palliat Care, 29(1), 64-69. doi:10.1177/1049909111412579

Birnbaum, D. J., Vigano, L., Ferrero, A., Langella, S., Russolillo, N., & Capussotti, L. (2014). Locally advanced gallbladder cancer: which patients benefit from resection? Eur J Surg Oncol, 40(8), 1008-1015. doi:10.1016/j.ejso.2013.10.014

Birnbaum, D. J., Vigano, L., Russolillo, N., Langella, S., Ferrero, A., & Capussotti, L. (2015). Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Ann Surg Oncol, 22(3), 811-818. doi:10.1245/s10434-014-4044-4

Bismuth, H., & Corlette, M. B. (1975). Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet, 140(2), 170-178.

Bismuth, H., & Krissat, J. (1999). Choledochal cystic malignancies. Ann Oncol, 10 Suppl 4, 94-98.

Bismuth, H., Nakache, R., & Diamond, T. (1992). Management strategies in resection for hilar cholangiocarcinoma. Ann Surg, 215(1), 31-38.

Bjornsson, E., Kilander, A., & Olsson, R. (1999). CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver, 19(6), 501-508.

Bjornsson, E., Lindqvist-Ottosson, J., Asztely, M., & Olsson, R. (2004). Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol, 99(3), 502-508. doi:10.1111/j.1572-0241.2004.04106.x

Blazeby, J. M., Currie, E., Zee, B. C., Chie, W. C., Poon, R. T., Garden, O. J., & Group, E. Q. o. L. (2004). Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Eur J Cancer, 40(16), 2439-2444. doi:10.1016/j.ejca.2004.06.033

Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J. (2011). Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol, 8(9), 512-522. doi:10.1038/nrgastro.2011.131

Blumgart LH, editor. Surgery of the liver and biliary tract. Edinburgh: Churchill Livingstone, 1988:721-52.

Boberg, K. M., Bergquist, A., Mitchell, S., Pares, A., Rosina, F., Broome, U., . . . Schrumpf, E. (2002). Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol, 37(10), 1205-1211.

Boberg, K. M., Jebsen, P., Clausen, O. P., Foss, A., Aabakken, L., & Schrumpf, E. (2006). Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol, 45(4), 568-574. doi:10.1016/j.jhep.2006.05.010

Boehm, L. M., Jayakrishnan, T. T., Miura, J. T., Zacharias, A. J., Johnston, F. M., Turaga, K. K., & Gamblin, T. C. (2015). Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. J Surg Oncol, 111(2), 213-220. doi:10.1002/jso.23781

Boldorini, R., Paganotti, A., Andorno, S., Orlando, S., Mercalli, F., Orsello, M., . . . Sartori, M. (2015). A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin. J Clin Pathol, 68(4), 283-287. doi:10.1136/jclinpath-2014-202731

Born, P., Rosch, T., Triptrap, A., Frimberger, E., Allescher, H. D., Ott, R., . . . Classen, M. (1998). Long-term results of percutaneous transhepatic biliary drainage for benign and malignant bile duct strictures. Scand J Gastroenterol, 33(5), 544-549.

Bosman FT, Carneiro F, Hruban RH, Theise ND (eds). WHO Classification of Tumours of the Digestive System (4th edition).  IARC Lyon,  2010.

Bower, T. C., & Nagorney, D. M. (1988). Mirizzi syndrome. HPB Surg, 1(1), 67-74; discussion 75-66.

Bragazzi MC, Cardinale V, Carpino G, et al. Cholangiocarcinoma: Epidemiology and risk factors. Transl Gastrointest Cancer 2012;1:21-32.

Brandsaeter, B., Isoniemi, H., Broome, U., Olausson, M., Backman, L., Hansen, B., . . . Bjoro, K. (2004). Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol, 40(5), 815-822. doi:10.1016/j.jhep.2004.01.002

Brannstrom, F., Bjerregaard, J. K., Winbladh, A., Nilbert, M., Revhaug, A., Wagenius, G., & Morner, M. (2015). Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer. Acta Oncol, 54(4), 447-453. doi:10.3109/0284186X.2014.952387

Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J. W., Patel, T., . . . Gores, G. J. (2014). Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol, 60(6), 1268-1289. doi:10.1016/j.jhep.2014.01.021

Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care, 7(2), 6-9.

Brugge, W., Dewitt, J., Klapman, J. B., Ashfaq, R., Shidham, V., Chhieng, D., . . . Papanicolaou Society of, C. (2014). Techniques for cytologic sampling of pancreatic and bile duct lesions. Diagn Cytopathol, 42(4), 333-337. doi:10.1002/dc.23096

Buffet, C., Fourre, C., Altman, C., Prat, F., Fritsch, J., Choury, A., . . . Etienne, J. P. (1996). Bile levels of carcino-embryonic antigen in patients with hepatopancreatobiliary disease. Eur J Gastroenterol Hepatol, 8(2), 131-134.

Burney, M., Purden, M., & McVey, L. (2002). Patient satisfaction and nurses' perceptions of quality in an inpatient cardiology population. J Nurs Care Qual, 16(4), 56-67; quiz 68-59.

Butte, J. M., Gonen, M., Allen, P. J., D'Angelica, M. I., Kingham, T. P., Fong, Y., . . . Jarnagin, W. R. (2011). The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford), 13(7), 463-472. doi:10.1111/j.1477-2574.2011.00325.x

Cairns, V., Neal, C. P., Dennison, A. R., & Garcea, G. (2012). Risk and Cost-effectiveness of Surveillance Followed by Cholecystectomy for Gallbladder Polyps. Arch Surg, 147(12), 1078-1083. doi:10.1001/archsurg.2012.1948

Cardinale, V., Semeraro, R., Torrice, A., Gatto, M., Napoli, C., Bragazzi, M. C., . . . Alvaro, D. (2010). Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol, 2(11), 407-416. doi:10.4251/wjgo.v2.i11.407

Cavazzoni, E., Bugiantella, W., Graziosi, L., Franceschini, M. S., & Donini, A. (2013). Malignant ascites: pathophysiology and treatment. Int J Clin Oncol, 18(1), 1-9. doi:10.1007/s10147-012-0396-6

Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., . . . Hoen, H. (2000). Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology, 31(1), 7-11. doi:10.1002/hep.510310103

Chang, W. H., Kortan, P., & Haber, G. B. (1998). Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc, 47(5), 354-362.

Chang, Y. R., Lee, K. B., Jang, J. Y., Lim, C. S., Kang, M. J., Kwon, W., . . . Kim, S. W. (2014). Analysis of microscopic tumor spread patterns according to gross morphologies and suggestions for optimal resection margins in bile duct cancer. J Gastrointest Surg, 18(6), 1146-1154. doi:10.1007/s11605-014-2518-0

Charatcharoenwitthaya, P., Enders, F. B., Halling, K. C., & Lindor, K. D. (2008). Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology, 48(4), 1106-1117. doi:10.1002/hep.22441

Chijiiwa, K., Yamaguchi, K., & Tanaka, M. (1997). Clinicopathologic differences between long-term and short-term postoperative survivors with advanced gallbladder carcinoma. World J Surg, 21(1), 98-102.

Chinai, N., Bintcliffe, F., Armstrong, E. M., Teape, J., Jones, B. M., & Hosie, K. B. (2013). Does every patient need to be discussed at a multidisciplinary team meeting? Clin Radiol, 68(8), 780-784. doi:10.1016/j.crad.2013.02.011

Choi, B. G., Kim, C. Y., Cho, S. H., Kim, H. J., Koh, Y. S., Kim, J. C., . . . Hur, Y. H. (2013). Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. J Korean Surg Soc, 84(3), 168-177. doi:10.4174/jkss.2013.84.3.168

Choi, B. I., Lee, J. M., & Han, J. K. (2004). Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging, 29(5), 548-557. doi:10.1007/s00261-004-0188-1

Choi, S. B., Han, H. J., Kim, C. Y., Kim, W. B., Song, T. J., Suh, S. O., . . . Choi, S. Y. (2010). Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection. J Gastrointest Surg, 14(4), 668-678. doi:10.1007/s11605-009-1132-z

Choi, S. B., Han, H. J., Kim, W. B., Song, T. J., Suh, S. O., & Choi, S. Y. (2013). Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary? Langenbecks Arch Surg, 398(8), 1137-1144. doi:10.1007/s00423-013-1120-3

Cholangiocarcinoma: A Nursing Perspective, Pack D. A, O’Connor K, O’Hagan K, Clinical Journal of Oncology Nursing (2001) VOLUME 5, NUMBER 4

Chung, Y. E., Kim, M. J., Park, Y. N., Choi, J. Y., Pyo, J. Y., Kim, Y. C., . . . Choi, S. Y. (2009). Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics, 29(3), 683-700. doi:10.1148/rg.293085729

Claudio A. Redaelli, MD, Markus W. Büchler, MD, Martin K. Schiiing, MD, Lukas Krähenbühl, MD, Charles Ruchti, MD, Leslie H. Blumgart, MD, and Hans U. Baer, MD, High coincidence of Mirizzi syndrome and gallbladder carcinoma Surgery 1996, Volume 121, Number 1.

Coburn, N. G., Cleary, S. P., Tan, J. C., & Law, C. H. (2008). Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg, 207(3), 371-382. doi:10.1016/j.jamcollsurg.2008.02.031

Coleman, E. A., Boult, C., & American Geriatrics Society Health Care Systems, C. (2003). Improving the quality of transitional care for persons with complex care needs. J Am Geriatr Soc, 51(4), 556-557.

Coolsen, M. M., Wong-Lun-Hing, E. M., van Dam, R. M., van der Wilt, A. A., Slim, K., Lassen, K., & Dejong, C. H. (2013). A systematic review of outcomes in patients undergoing liver surgery in an enhanced recovery after surgery pathways. HPB (Oxford), 15(4), 245-251. doi:10.1111/j.1477-2574.2012.00572.x

Corvera, C. U., Blumgart, L. H., Akhurst, T., DeMatteo, R. P., D'Angelica, M., Fong, Y., & Jarnagin, W. R. (2008). 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg, 206(1), 57-65. doi:10.1016/j.jamcollsurg.2007.07.002

Corwin, M. T., Siewert, B., Sheiman, R. G., & Kane, R. A. (2011). Incidentally detected gallbladder polyps: is follow-up necessary?--Long-term clinical and US analysis of 346 patients. Radiology, 258(1), 277-282. doi:10.1148/radiol.10100273

Costi, R., Randone, B., Violi, V., Scatton, O., Sarli, L., Soubrane, O., . . . Montariol, T. (2009). Cholecystocolonic fistula: facts and myths. A review of the 231 published cases. J Hepatobiliary Pancreat Surg, 16(1), 8-18. doi:10.1007/s00534-008-0014-1

D'Angelica, M., Dalal, K. M., DeMatteo, R. P., Fong, Y., Blumgart, L. H., & Jarnagin, W. R. (2009). Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol, 16(4), 806-816. doi:10.1245/s10434-008-0189-3

Dahlstrand, U., Sandblom, G., Eriksson, L. G., Nyman, R., & Rasmussen, I. C. (2009). Primary patency of percutaneously inserted self-expanding metallic stents in patients with malignant biliary obstruction. HPB (Oxford), 11(4), 358-363. doi:10.1111/j.1477-2574.2009.00069.x

Dambrauskas, Z., Paskauskas, S., Lizdenis, P., Uktveris, R., Pranculis, A., Kaupas, R. S., . . . Pundzius, J. (2008). Percutaneous transhepatic biliary stenting: the first experience and results of the Hospital of Kaunas University of Medicine. Medicina (Kaunas), 44(12), 969-976.

Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., . . . Heimbach, J. K. (2012). Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology, 143(1), 88-98 e83; quiz e14. doi:10.1053/j.gastro.2012.04.008

de Aretxabala, X., Roa, I., Burgos, L., Losada, H., Roa, J. C., Mora, J., . . . Maluenda, F. (2006). Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. J Gastrointest Surg, 10(2), 186-192. doi:10.1016/j.gassur.2005.11.003

de Bellis, M., Fogel, E. L., Sherman, S., Watkins, J. L., Chappo, J., Younger, C., . . . Lehman, G. A. (2003). Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc, 58(2), 176-182. doi:10.1067/mge.2003.345

de Jong, M. C., Hong, S. M., Augustine, M. M., Goggins, M. G., Wolfgang, C. L., Hirose, K., . . . Pawlik, T. M. (2011). Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg, 146(6), 697-703. doi:10.1001/archsurg.2011.122

de Jong, M. C., Nathan, H., Sotiropoulos, G. C., Paul, A., Alexandrescu, S., Marques, H., . . . Pawlik, T. M. (2011). Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol, 29(23), 3140-3145. doi:10.1200/JCO.2011.35.6519

De Palma, G. D., Galloro, G., Siciliano, S., Iovino, P., & Catanzano, C. (2001). Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc, 53(6), 547-553.

Deoliveira, M. L., Schulick, R. D., Nimura, Y., Rosen, C., Gores, G., Neuhaus, P., & Clavien, P. A. (2011). New staging system and a registry for perihilar cholangiocarcinoma. Hepatology, 53(4), 1363-1371. doi:10.1002/hep.24227

Donohue JH, Nagorney DM, Grant CS et al. An aggressive surgical approach leads to improved survival  in patients with gall bladder cancer. Does radical resection improve outcome? Arch Surg 2005; 125: 237-241.

Downing, S. R., Cadogan, K. A., Ortega, G., Oyetunji, T. A., Siram, S. M., Chang, D. C., . . . Frederick, W. A. (2011). Early-stage gallbladder cancer in the Surveillance, Epidemiology, and End Results database: effect of extended surgical resection. Arch Surg, 146(6), 734-738. doi:10.1001/archsurg.2011.128

Duffy, A., Capanu, M., Abou-Alfa, G. K., Huitzil, D., Jarnagin, W., Fong, Y., . . . O'Reilly, E. M. (2008). Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol, 98(7), 485-489. doi:10.1002/jso.21141

Ebata, T., Yokoyama, Y., Igami, T., Sugawara, G., Mizuno, T., & Nagino, M. (2014). Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin. J Hepatobiliary Pancreat Sci, 21(8), 550-555. doi:10.1002/jhbp.80

Edge, S. B., & Compton, C. C. (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17(6), 1471-1474. doi:10.1245/s10434-010-0985-4

Edge SB, Byrd DR, Comptom CC, Fritz AG, Grenne FL, Trotti A (eds). AJCC Cancer Staging Manual (7th edition). Springer, 2010.

Ekbom, A., Hsieh, C. C., Yuen, J., Trichopoulos, D., McLaughlin, J. K., Lan, S. J., & Adami, H. O. (1993). Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet, 342(8882), 1262-1265.

Elmasry, M., Lindop, D., Dunne, D. F., Malik, H., Poston, G. J., & Fenwick, S. W. (2016). The risk of malignancy in ultrasound detected gallbladder polyps: A systematic review. Int J Surg, 33 Pt A, 28-35. doi:10.1016/j.ijsu.2016.07.061

Elsayes, K. M., Oliveira, E. P., Narra, V. R., Abou El Abbass, H. A., Ahmed, M. I., Tongdee, R., & Brown, J. J. (2006). MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings. J Comput Assist Tomogr, 30(3), 398-404.

Endo, I., Shimada, H., Fujii, Y., Sugita, M., Masunari, H., Miura, Y., . . . Togo, S. (2001). Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J Hepatobiliary Pancreat Surg, 8(6), 505-510. doi:10.1007/s005340100017

Eun, H. W., Kim, J. H., Hong, S. S., & Kim, Y. J. (2012). Malignant versus benign hepatic masses in patients with recurrent pyogenic cholangitis: MR differential diagnosis. Abdom Imaging, 37(5), 767-774. doi:10.1007/s00261-011-9833-7

European Partnership Action Against Cancer consensus, g., Borras, J. M., Albreht, T., Audisio, R., Briers, E., Casali, P., . . . Wilson, R. (2014). Policy statement on multidisciplinary cancer care. Eur J Cancer, 50(3), 475-480. doi:10.1016/j.ejca.2013.11.012

Fan, S. Y., Eiser, C., & Ho, M. C. (2010). Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol, 8(7), 559-564 e551-510. doi:10.1016/j.cgh.2010.03.008

Fang, Y., Gurusamy, K. S., Wang, Q., Davidson, B. R., Lin, H., Xie, X., & Wang, C. (2012). Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev, 9, CD005444. doi:10.1002/14651858.CD005444.pub3

Farges, O., Regimbeau, J. M., Fuks, D., Le Treut, Y. P., Cherqui, D., Bachellier, P., . . . Gigot, J. F. (2013). Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg, 100(2), 274-283. doi:10.1002/bjs.8950

Fernandez, E., La Vecchia, C., D'Avanzo, B., Negri, E., & Franceschi, S. (1994). Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 3(3), 209-212.

Fiteni, F., Nguyen, T., Vernerey, D., Paillard, M. J., Kim, S., Demarchi, M., . . . Pivot, X. (2014). Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review. Cancer Med, 3(6), 1502-1511. doi:10.1002/cam4.299

Fong, Y., Jarnagin, W., & Blumgart, L. H. (2000). Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg, 232(4), 557-569.

Friend, E., Yadegarfar, G., Byrne, C., Johnson, C. D., Sezer, O., Pucciarelli, S., . . . Group, E. Q. o. L. (2011). Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21. Br J Cancer, 104(4), 587-592. doi:10.1038/sj.bjc.6606086

Fritscher-Ravens, A., Bohuslavizki, K. H., Broering, D. C., Jenicke, L., Schafer, H., Buchert, R., . . . Clausen, M. (2001). FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun, 22(12), 1277-1285.

Fuks, D., Regimbeau, J. M., Le Treut, Y. P., Bachellier, P., Raventos, A., Pruvot, F. R., . . . Farges, O. (2011). Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg, 35(8), 1887-1897. doi:10.1007/s00268-011-1134-3

Fumino, S., Higuchi, K., Aoi, S., Furukawa, T., Kimura, O., & Tajiri, T. (2013). Clinical analysis of liver fibrosis in choledochal cyst. Pediatr Surg Int, 29(11), 1097-1102. doi:10.1007/s00383-013-3368-7

Furlan, A., Ferris, J. V., Hosseinzadeh, K., & Borhani, A. A. (2008). Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR Am J Roentgenol, 191(5), 1440-1447. doi:10.2214/AJR.07.3599

Gallardo, J. O., Rubio, B., Fodor, M., Orlandi, L., Yanez, M., Gamargo, C., & Ahumada, M. (2001). A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol, 12(10), 1403-1406.

Gerhards, M. F., Gonzalez, D. G., ten Hoopen-Neumann, H., van Gulik, T. M., de Wit, L. T., & Gouma, D. J. (2000). Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. Eur J Surg Oncol, 26(5), 480-485.

Glimelius, B., Hoffman, K., Sjoden, P. O., Jacobsson, G., Sellstrom, H., Enander, L. K., . . . Svensson, C. (1996). Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol, 7(6), 593-600.

Goetze, T. O., & Paolucci, V. (2008). Immediate re-resection of T1 incidental gallbladder carcinomas: a survival analysis of the German Registry. Surg Endosc, 22(11), 2462-2465. doi:10.1007/s00464-008-9747-9

Goetze, T. O., & Paolucci, V. (2010). Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc, 24(9), 2156-2164. doi:10.1007/s00464-010-0914-4

Goetze, T. O., & Paolucci, V. (2012). The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry. Surg Endosc, 26(5), 1382-1389. doi:10.1007/s00464-011-2044-z

Goetze, T. O., & Paolucci, V. (2013). Prognosis of incidental gallbladder carcinoma is not influenced by the primary access technique: analysis of 837 incidental gallbladder carcinomas in the German Registry. Surg Endosc, 27(8), 2821-2828. doi:10.1007/s00464-013-2819-5

Goetze, T. O., & Paolucci, V. (2014). [Incidental T1b-T3 gallbladder carcinoma. Extended cholecystectomy as an underestimated prognostic factor-results of the German registry]. Chirurg, 85(2), 131-138. doi:10.1007/s00104-013-2587-8

Goldhill, D. R., McNarry, A. F., Hadjianastassiou, V. G., & Tekkis, P. P. (2004). The longer patients are in hospital before Intensive Care admission the higher their mortality. Intensive Care Med, 30(10), 1908-1913. doi:10.1007/s00134-004-2386-2

Gonda, T. A., Glick, M. P., Sethi, A., Poneros, J. M., Palmas, W., Iqbal, S., . . . Stevens, P. D. (2012). Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. Gastrointest Endosc, 75(1), 74-79. doi:10.1016/j.gie.2011.08.022

Gotthardt, D. N., Rudolph, G., Kloters-Plachky, P., Kulaksiz, H., & Stiehl, A. (2010). Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc, 71(3), 527-534. doi:10.1016/j.gie.2009.10.041

Greer, J. A., Pirl, W. F., Jackson, V. A., Muzikansky, A., Lennes, I. T., Heist, R. S., . . . Temel, J. S. (2012). Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol, 30(4), 394-400. doi:10.1200/JCO.2011.35.7996

Grundmann, S., & Stander, S. (2011). Chronic pruritus: clinics and treatment. Ann Dermatol, 23(1), 1-11. doi:10.5021/ad.2011.23.1.1

Guglielmi, A., Ruzzenente, A., Campagnaro, T., Pachera, S., Valdegamberi, A., Nicoli, P., . . . Iacono, C. (2009). Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg, 33(6), 1247-1254. doi:10.1007/s00268-009-9970-0

Guiu, B., Bize, P., Gunthern, D., Demartines, N., Halkic, N., & Denys, A. (2013). Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Intervent Radiol, 36(5), 1306-1312. doi:10.1007/s00270-013-0565-7

 Gustafsson, B. (2004). Bekräftande omvårdnad: SAUK-modellen för vård och omsorg. Lund: Studentlitteratur.

Halling, K. C., King, W., Sokolova, I. A., Meyer, R. G., Burkhardt, H. M., Halling, A. C., . . . Jenkins, R. B. (2000). A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol, 164(5), 1768-1775.

Han, J. K., Choi, B. I., Kim, A. Y., An, S. K., Lee, J. W., Kim, T. K., & Kim, S. W. (2002). Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics, 22(1), 173-187. doi:10.1148/radiographics.22.1.g02ja15173

Harder, J., Riecken, B., Kummer, O., Lohrmann, C., Otto, F., Usadel, H., . . . Henss, H. (2006). Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br J Cancer, 95(7), 848-852. doi:10.1038/sj.bjc.6603334

Harewood, G. C., & Baron, T. H. (2002). Cost analysis of magnetic resonance cholangiography in the management of inoperable hilar biliary obstruction. Am J Gastroenterol, 97(5), 1152-1158. doi:10.1111/j.1572-0241.2002.05682.x

Hari, D. M., Howard, J. H., Leung, A. M., Chui, C. G., Sim, M. S., & Bilchik, A. J. (2013). A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB (Oxford), 15(1), 40-48. doi:10.1111/j.1477-2574.2012.00559.x

Hassoun, Z., Gores, G. J., & Rosen, C. B. (2002). Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am, 11(4), 909-921.

He, X. D., Li, J. J., Liu, W., Qu, Q., Hong, T., Xu, X. Q., . . . Zhao, H. T. (2015). Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer. World J Gastroenterol, 21(15), 4620-4626. doi:10.3748/wjg.v21.i15.4620

Heimbach, J. K., Gores, G. J., Haddock, M. G., Alberts, S. R., Nyberg, S. L., Ishitani, M. B., & Rosen, C. B. (2004). Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis, 24(2), 201-207. doi:10.1055/s-2004-828896

Hemming, A. W., Reed, A. I., Fujita, S., Foley, D. P., & Howard, R. J. (2005). Surgical management of hilar cholangiocarcinoma. Ann Surg, 241(5), 693-699; discussion 699-702.

Hemminki, K., & Li, X. (2003). Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut, 52(4), 592-596.

Hidalgo, E., Asthana, S., Nishio, H., Wyatt, J., Toogood, G. J., Prasad, K. R., & Lodge, J. P. (2008). Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol, 34(7), 787-794. doi:10.1016/j.ejso.2007.10.005

Higuchi, R., Ota, T., Araida, T., Kajiyama, H., Yazawa, T., Furukawa, T., . . . Yamamoto, M. (2014). Surgical approaches to advanced gallbladder cancer : a 40-year single-institution study of prognostic factors and resectability. Ann Surg Oncol, 21(13), 4308-4316. doi:10.1245/s10434-014-3885-1

Hintze, R. E., Abou-Rebyeh, H., Adler, A., Veltzke-Schlieker, W., Felix, R., & Wiedenmann, B. (2001). Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc, 53(1), 40-46. doi:10.1067/mge.2001.111388

Hoffmann, R. T., Paprottka, P. M., Schon, A., Bamberg, F., Haug, A., Durr, E. M., . . . Kolligs, F. T. (2012). Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol, 35(1), 105-116. doi:10.1007/s00270-011-0142-x

Horgan, A. M., Amir, E., Walter, T., & Knox, J. J. (2012). Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol, 30(16), 1934-1940. doi:10.1200/JCO.2011.40.5381

Horiguchi, A., Miyakawa, S., Ishihara, S., Miyazaki, M., Ohtsuka, M., Shimizu, H., . . . Takada, T. (2013). Gallbladder bed resection or hepatectomy of segments 4a and 5 for pT2 gallbladder carcinoma: analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci, 20(5), 518-524. doi:10.1007/s00534-012-0584-9

Howell, M., & Valle, J. W. (2015). The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma. Best Pract Res Clin Gastroenterol, 29(2), 333-343. doi:10.1016/j.bpg.2015.03.001

Huang, C. S., Huang, C. C., & Chen, D. F. (2010). Choledochal cysts: differences between pediatric and adult patients. J Gastrointest Surg, 14(7), 1105-1110. doi:10.1007/s11605-010-1209-8

Ibrahim, S. M., Mulcahy, M. F., Lewandowski, R. J., Sato, K. T., Ryu, R. K., Masterson, E. J., . . . Salem, R. (2008). Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer, 113(8), 2119-2128. doi:10.1002/cncr.23818

Iida, H., Aihara, T., Ikuta, S., Yoshie, H., & Yamanaka, N. (2012). Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation. World J Gastroenterol, 18(19), 2371-2376. doi:10.3748/wjg.v18.i19.2371

Iqbal, S., Rankin, C., Lenz, H. J., Gold, P. J., Ahmad, S. A., El-Khoueiry, A. B., . . . Blanke, C. D. (2011). A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. Cancer Chemother Pharmacol, 68(6), 1595-1602. doi:10.1007/s00280-011-1657-1

Ishibashi, H., Shimada, M., Kamisawa, T., Fujii, H., Hamada, Y., Kubota, M., . . . Ando, H. (2017). Japanese clinical practice guidelines for congenital biliary dilatation. J Hepatobiliary Pancreat Sci, 24(1), 1-16. doi:10.1002/jhbp.415

Ishikawa, T., Horimi, T., Shima, Y., Okabayashi, T., Nishioka, Y., Hamada, M., . . . Morita, S. (2003). Evaluation of aggressive surgical treatment for advanced carcinoma of the gallbladder. J Hepatobiliary Pancreat Surg, 10(3), 233-238. doi:10.1007/s00534-003-0848-5

Itano, O., Oshima, G., Minagawa, T., Shinoda, M., Kitago, M., Abe, Y., . . . Kitagawa, Y. (2015). Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surg Endosc. doi:10.1007/s00464-015-4116-y

Itoi, T., Kamisawa, T., Igarashi, Y., Kawakami, H., Yasuda, I., Itokawa, F., . . . Baron, T. H. (2013). The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol, 48(4), 504-514. doi:10.1007/s00535-012-0652-6

Jan, Y. Y., Chen, H. M., & Chen, M. F. (2002). Malignancy in choledochal cysts. Hepatogastroenterology, 49(43), 100-103.

Jarnagin, W. R., Bowne, W., Klimstra, D. S., Ben-Porat, L., Roggin, K., Cymes, K., . . . Blumgart, L. H. (2005). Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg, 241(5), 703-712; discussion 712-704.

Jarnagin, W. R., Fong, Y., DeMatteo, R. P., Gonen, M., Burke, E. C., Bodniewicz, B. J., . . . Blumgart, L. H. (2001). Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg, 234(4), 507-517; discussion 517-509.

Jarnagin, W. R., Ruo, L., Little, S. A., Klimstra, D., D'Angelica, M., DeMatteo, R. P., . . . Fong, Y. (2003). Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer, 98(8), 1689-1700. doi:10.1002/cncr.11699

Jensen, E. H., Abraham, A., Habermann, E. B., Al-Refaie, W. B., Vickers, S. M., Virnig, B. A., & Tuttle, T. M. (2009). A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg, 13(4), 722-727. doi:10.1007/s11605-008-0772-8

Jensen, E. H., Abraham, A., Jarosek, S., Habermann, E. B., Al-Refaie, W. B., Vickers, S. A., . . . Tuttle, T. M. (2009). Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery, 146(4), 706-711; discussion 711-703. doi:10.1016/j.surg.2009.06.056

Jones, C., Kelliher, L., Dickinson, M., Riga, A., Worthington, T., Scott, M. J., . . . Quiney, N. (2013). Randomized clinical trial on enhanced recovery versus standard care following open liver resection. Br J Surg, 100(8), 1015-1024. doi:10.1002/bjs.9165

Jones, K. R., Burney, R. E., & Christy, B. (2000). Patient expectations for surgery: are they being met? Jt Comm J Qual Improv, 26(6), 349-360.

Joo, I., & Lee, J. M. (2013). Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging, 38(6), 1334-1350. doi:10.1007/s00261-013-0027-3

Jun, S. R., Lee, J. M., Han, J. K., & Choi, B. I. (2006). High-grade neuroendocrine carcinomas of the gallbladder and bile duct: Report of four cases with pathological correlation. J Comput Assist Tomogr, 30(4), 604-609.

Juntermanns, B., Radunz, S., Heuer, M., Hertel, S., Reis, H., Neuhaus, J. P., . . . Kaiser, G. M. (2010). Tumor markers as a diagnostic key for hilar cholangiocarcinoma. Eur J Med Res, 15(8), 357-361.

Kai, K., Aishima, S., & Miyazaki, K. (2014). Gallbladder cancer: Clinical and pathological approach. World J Clin Cases, 2(10), 515-521. doi:10.12998/wjcc.v2.i10.515

Kai, M., Chijiiwa, K., Ohuchida, J., Nagano, M., Hiyoshi, M., & Kondo, K. (2007). A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma. J Gastrointest Surg, 11(8), 1025-1032. doi:10.1007/s11605-007-0181-4

Kamisawa, T., & Okamoto, A. (2006). Biliopancreatic and pancreatobiliary refluxes in cases with and without pancreaticobiliary maljunction: diagnosis and clinical implications. Digestion, 73(4), 228-236. doi:10.1159/000095424

Kang, M. J., Choi, Y. S., Jang, J. Y., Han, I. W., & Kim, S. W. (2013). Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma. World J Surg, 37(2), 437-442. doi:10.1007/s00268-012-1844-1

Kang, M. J., Song, Y., Jang, J. Y., Han, I. W., & Kim, S. W. (2012). Role of radical surgery in patients with stage IV gallbladder cancer. HPB (Oxford), 14(12), 805-811. doi:10.1111/j.1477-2574.2012.00544.x

Kang, Y., Lee, J. M., Kim, S. H., Han, J. K., & Choi, B. I. (2012). Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology, 264(3), 751-760. doi:10.1148/radiol.12112308

Kawakami, H., Kuwatani, M., Etoh, K., Haba, S., Yamato, H., Shinada, K., . . . Asaka, M. (2009). Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy, 41(11), 959-964. doi:10.1055/s-0029-1215178

Kawakami, H., Kuwatani, M., Onodera, M., Haba, S., Eto, K., Ehira, N., . . . Asaka, M. (2011). Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol, 46(2), 242-248. doi:10.1007/s00535-010-0298-1

Kayahara, M., Nagakawa, T., Nakagawara, H., Kitagawa, H., & Ohta, T. (2008). Prognostic factors for gallbladder cancer in Japan. Ann Surg, 248(5), 807-814. doi:10.1097/SLA.0b013e31818a1561

Keulers, B. J., Scheltinga, M. R., Houterman, S., Van Der Wilt, G. J., & Spauwen, P. H. (2008). Surgeons underestimate their patients' desire for preoperative information. World J Surg, 32(6), 964-970. doi:10.1007/s00268-008-9581-1

Khan, S. A., Davidson, B. R., Goldin, R. D., Heaton, N., Karani, J., Pereira, S. P., . . . British Society of, G. (2012). Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut, 61(12), 1657-1669. doi:10.1136/gutjnl-2011-301748

Kim, D. H., Kim, S. H., Choi, G. H., Kang, C. M., Kim, K. S., Choi, J. S., & Lee, W. J. (2013). Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer. World J Surg, 37(11), 2635-2640. doi:10.1007/s00268-013-2187-2

Kim, H., Lim, J. H., Jang, K. T., Kim, M. J., Lee, J., Lee, J. Y., . . . Baron, R. (2011). Morphology of intraductal papillary neoplasm of the bile ducts: radiologic-pathologic correlation. Abdom Imaging, 36(4), 438-446. doi:10.1007/s00261-010-9636-2

Kim, J. E., Lee, J. M., Kim, S. H., Baek, J. H., Moon, S. K., Yu, I. S., . . . Choi, B. I. (2010). Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology, 257(2), 364-372. doi:10.1148/radiol.10092105

Kim, J. H., Yoon, H. K., Sung, K. B., Ko, G. Y., Gwon, D. I., Shin, J. H., & Song, H. Y. (2008). Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer, 113(7), 1614-1622. doi:10.1002/cncr.23787

Kim, N. R., Lee, J. M., Kim, S. H., An, S. K., Han, C. J., Choi, S. H., . . . Choi, B. I. (2008). Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. Clin Imaging, 32(2), 114-120. doi:10.1016/j.clinimag.2007.08.022

Kim, S. A., Lee, J. M., Lee, K. B., Kim, S. H., Yoon, S. H., Han, J. K., & Choi, B. I. (2011). Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology, 260(1), 148-157. doi:10.1148/radiol.11101777

Kim, S. J., Lee, J. M., Han, J. K., Kim, K. H., Lee, J. Y., & Choi, B. I. (2007). Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol, 189(6), 1428-1434. doi:10.2214/AJR.07.2484

Kim, W. S., Choi, D. W., You, D. D., Ho, C. Y., Heo, J. S., & Choi, S. H. (2010). Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg, 14(4), 679-687. doi:10.1007/s11605-009-1140-z

Kloek, J. J., van der Gaag, N. A., Aziz, Y., Rauws, E. A., van Delden, O. M., Lameris, J. S., . . . van Gulik, T. M. (2010). Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg, 14(1), 119-125. doi:10.1007/s11605-009-1009-1

Koh, C. Y., Demirjian, A. N., Chen, W. P., McLaren, C. E., & Imagawa, D. K. (2013). Validation of revised American Joint Committee on Cancer staging for gallbladder cancer based on a single institution experience. Am Surg, 79(10), 1045-1049.

Komuta, M., Govaere, O., Vandecaveye, V., Akiba, J., Van Steenbergen, W., Verslype, C., . . . Roskams, T. (2012). Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology, 55(6), 1876-1888. doi:10.1002/hep.25595

Komuta, M., Spee, B., Vander Borght, S., De Vos, R., Verslype, C., Aerts, R., . . . Roskams, T. (2008). Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology, 47(5), 1544-1556. doi:10.1002/hep.22238

Kuhlmann, J. B., Euringer, W., Spangenberg, H. C., Breidert, M., Blum, H. E., Harder, J., & Fischer, R. (2012). Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. Eur J Gastroenterol Hepatol, 24(4), 437-443. doi:10.1097/MEG.0b013e3283502241

Kullman, E., Frozanpor, F., Soderlund, C., Linder, S., Sandstrom, P., Lindhoff-Larsson, A., . . . Eriksson, O. (2010). Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc, 72(5), 915-923. doi:10.1016/j.gie.2010.07.036

Kurtycz, D. F., Field, A., Tabatabai, L., Michaels, C., Young, N., Schmidt, C. M., . . . Pitman, M. B. (2014). Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology Guidelines. Cytojournal, 11(Suppl 1), 5. doi:10.4103/1742-6413.133356

Kwon, Y. J., & Lee, K. G. (2014). Is T-stage the only significant factor determining the extent of surgery for gallbladder cancer? Hepatogastroenterology, 61(130), 304-306.

Lamarca, A., Hubner, R. A., David Ryder, W., & Valle, J. W. (2014). Second-line chemotherapy in advanced biliary cancer: a systematic review. Ann Oncol, 25(12), 2328-2338. doi:10.1093/annonc/mdu162

Lawson, A. J., Beningfield, S. J., Krige, J. E., Rischbieter, P., & Burmeister, S. (2012). Percutaneous transhepatic self-expanding metal stents for palliation of malignant biliary obstruction. S Afr J Surg, 50(3), 54, 56, 58 passim.

Layfield, L. J., Dodd, L., Factor, R., & Schmidt, R. L. (2014). Malignancy risk associated with diagnostic categories defined by the Papanicolaou Society of Cytopathology pancreaticobiliary guidelines. Cancer Cytopathol, 122(6), 420-427. doi:10.1002/cncy.21386

Layfield, L. J., Ehya, H., Filie, A. C., Hruban, R. H., Jhala, N., Joseph, L., . . . Pitman, M. B. (2014). Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The Papanicolaou Society of Cytopathology Guidelines. Cytojournal, 11(Suppl 1), 4. doi:10.4103/1742-6413.133352

Lee, J. W., Han, J. K., Kim, T. K., Kim, Y. H., Choi, B. I., Han, M. C., . . . Kim, S. W. (2000). CT features of intraductal intrahepatic cholangiocarcinoma. AJR Am J Roentgenol, 175(3), 721-725. doi:10.2214/ajr.175.3.1750721

Lee, K. F., Wong, J., Li, J. C., & Lai, P. B. (2004). Polypoid lesions of the gallbladder. Am J Surg, 188(2), 186-190. doi:10.1016/j.amjsurg.2003.11.043

Lee, S. E., Jang, J. Y., Lim, C. S., Kang, M. J., & Kim, S. W. (2011). Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol, 17(2), 174-180. doi:10.3748/wjg.v17.i2.174

Levy, A. D., Murakata, L. A., & Rohrmann, C. A., Jr. (2001). Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics, 21(2), 295-314; questionnaire, 549-255. doi:10.1148/radiographics.21.2.g01mr16295

Li, J., Kuehl, H., Grabellus, F., Muller, S. P., Radunz, S., Antoch, G., . . . Kaiser, G. M. (2008). Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol, 98(6), 438-443. doi:10.1002/jso.21136

Lim, H., Seo, D. W., Park do, H., Lee, S. S., Lee, S. K., Kim, M. H., & Hwang, S. (2013). Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients. J Clin Gastroenterol, 47(5), 443-448. doi:10.1097/MCG.0b013e3182703409

Lim, J. H. (2003). Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol, 181(3), 819-827. doi:10.2214/ajr.181.3.1810819

Lim, J. H., Kim, Y. I., & Park, C. K. (2000). Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver. Abdom Imaging, 25(1), 89-92.

Lim, J. H., Yoon, K. H., Kim, S. H., Kim, H. Y., Lim, H. K., Song, S. Y., & Nam, K. J. (2004). Intraductal papillary mucinous tumor of the bile ducts. Radiographics, 24(1), 53-66; discussion 66-57. doi:10.1148/rg.241035002

Lindberg, B., Arnelo, U., Bergquist, A., Thorne, A., Hjerpe, A., Granqvist, S., . . . Broome, U. (2002). Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy, 34(11), 909-916. doi:10.1055/s-2002-35298

Lindström D. The impact of tobacco use on postoperative complications [avhandling]. Stockholm: Karolinska institutet; 2008

Lithner, M., & Zilling, T. (2000). Pre- and postoperative information needs. Patient Educ Couns, 40(1), 29-37.

Lithner, M. and T. Zilling, Does preoperative information increase the wellbeing of the patient after surgery? (in Swedish) Vår d i Norden 1998; 18:31-33,39,1998.

Liu, F., Li, Y., Wei, Y., & Li, B. (2011). Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci, 56(3), 663-672. doi:10.1007/s10620-010-1338-7

Liu, G. J., Li, X. H., Chen, Y. X., Sun, H. D., Zhao, G. M., & Hu, S. Y. (2013). Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis. World J Gastroenterol, 19(31), 5150-5158. doi:10.3748/wjg.v19.i31.5150

Mabrut, J. Y., Kianmanesh, R., Nuzzo, G., Castaing, D., Boudjema, K., Letoublon, C., . . . Gigot, J. F. (2013). Surgical management of congenital intrahepatic bile duct dilatation, Caroli's disease and syndrome: long-term results of the French Association of Surgery Multicenter Study. Ann Surg, 258(5), 713-721; discussion 721. doi:10.1097/SLA.0000000000000269

Madoff, D. C., Hicks, M. E., Abdalla, E. K., Morris, J. S., & Vauthey, J. N. (2003). Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients. Radiology, 227(1), 251-260. doi:10.1148/radiol.2271012010

Mayo, S. C., Shore, A. D., Nathan, H., Edil, B., Wolfgang, C. L., Hirose, K., . . . Pawlik, T. M. (2010). National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg, 14(10), 1578-1591. doi:10.1007/s11605-010-1335-3

Meng, H., Wang, X., Fong, Y., Wang, Z. H., Wang, Y., & Zhang, Z. T. (2011). Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol, 41(8), 992-998. doi:10.1093/jjco/hyr072

Meyer, C. G., Penn, I., & James, L. (2000). Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation, 69(8), 1633-1637.

Miller, G., & Jarnagin, W. R. (2008). Gallbladder carcinoma. Eur J Surg Oncol, 34(3), 306-312. doi:10.1016/j.ejso.2007.07.206

Miura, J. T., Johnston, F. M., Tsai, S., George, B., Thomas, J., Eastwood, D., . . . Clark Gamblin, T. (2015). Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. doi:10.1245/s10434-015-4501-8

Monga, A., Ramchandani, M., & Reddy, D. N. (2011). Per-oral cholangioscopy. J Interv Gastroenterol, 1(2), 70-77. doi:10.4161/jig.1.2.15352

Moon, J. H., & Choi, H. J. (2013). The role of direct peroral cholangioscopy using an ultraslim endoscope for biliary lesions: indications, limitations, and complications. Clin Endosc, 46(5), 537-539. doi:10.5946/ce.2013.46.5.537

Moon, J. H., Terheggen, G., Choi, H. J., & Neuhaus, H. (2013). Peroral cholangioscopy: diagnostic and therapeutic applications. Gastroenterology, 144(2), 276-282. doi:10.1053/j.gastro.2012.10.045

Morine, Y., Shimada, M., Takamatsu, H., Araida, T., Endo, I., Kubota, M., . . . Shimada, H. (2013). Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci, 20(5), 472-480. doi:10.1007/s00534-013-0606-2

Morris-Stiff, G., Bhati, C., Olliff, S., Hubscher, S., Gunson, B., Mayer, D., . . . Bramhall, S. R. (2008). Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience. Dig Surg, 25(2), 126-132. doi:10.1159/000128169

Mouli, S., Memon, K., Baker, T., Benson, A. B., 3rd, Mulcahy, M. F., Gupta, R., . . . Lewandowski, R. J. (2013). Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol, 24(8), 1227-1234. doi:10.1016/j.jvir.2013.02.031

Muir, C. A. (2004). Acute ascending cholangitis. Clin J Oncol Nurs, 8(2), 157-160. doi:10.1188/04.CJON.157-160

Murakami, Y., Uemura, K., Sudo, T., Hashimoto, Y., Nakashima, A., Kondo, N., . . . Sueda, T. (2011). Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma? World J Surg, 35(5), 1085-1093. doi:10.1007/s00268-011-1036-4

Nagino, M., Kamiya, J., Nishio, H., Ebata, T., Arai, T., & Nimura, Y. (2006). Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg, 243(3), 364-372. doi:10.1097/01.sla.0000201482.11876.14

Nagino, M., Takada, T., Miyazaki, M., Miyakawa, S., Tsukada, K., Kondo, S., . . . Japan Society of Clinical, O. (2008). Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg, 15(1), 25-30. doi:10.1007/s00534-007-1277-7

Nakanuma, Y., Sasaki, M., Ikeda, H., Sato, Y., Zen, Y., Kosaka, K., & Harada, K. (2008). Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol Res, 38(4), 325-334. doi:10.1111/j.1872-034X.2007.00312.x

NANDA-international, Omvårdnadsdiagnoser – definition och klassifikation 2012-2014, Studentlitteratur 2013, översättning Jan Florin.

Narayanan, S. K., Chen, Y., Narasimhan, K. L., & Cohen, R. C. (2013). Hepaticoduodenostomy versus hepaticojejunostomy after resection of choledochal cyst: a systematic review and meta-analysis. J Pediatr Surg, 48(11), 2336-2342. doi:10.1016/j.jpedsurg.2013.07.020

Nathan, H., & Pawlik, T. M. (2010). Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol, 26(3), 269-273. doi:10.1097/MOG.0b013e328337c899

Nationella riktlinjer för bröst-, prostata-,tjocktarms- och ändtarmscancervård 2014. Socialstyrelsen ISBN 978-91-7555-162-3.

Neuhaus, P., Jonas, S., Bechstein, W. O., Lohmann, R., Radke, C., Kling, N., . . . Hintze, R. (1999). Extended resections for hilar cholangiocarcinoma. Ann Surg, 230(6), 808-818; discussion 819.

Neuhaus, P., Thelen, A., Jonas, S., Puhl, G., Denecke, T., Veltzke-Schlieker, W., & Seehofer, D. (2012). Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol, 19(5), 1602-1608. doi:10.1245/s10434-011-2077-5

Nichols, J. C., Gores, G. J., LaRusso, N. F., Wiesner, R. H., Nagorney, D. M., & Ritts, R. E., Jr. (1993). Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc, 68(9), 874-879.

Nimura, Y., Hayakawa, N., Kamiya, J., Kondo, S., & Shionoya, S. (1990). Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg, 14(4), 535-543; discussion 544.

Noji, T., Tsuchikawa, T., Mizota, T., Okamura, K., Nakamura, T., Tamoto, E., . . . Hirano, S. (2015). Surgery for recurrent biliary carcinoma: results for 27 recurrent cases. World J Surg Oncol, 13, 82. doi:10.1186/s12957-015-0507-8

Nuzzo, G., Giuliante, F., Ardito, F., Giovannini, I., Aldrighetti, L., Belli, G., . . . Federico, B. (2012). Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg, 147(1), 26-34. doi:10.1001/archsurg.2011.771

Oh, T. G., Chung, M. J., Bang, S., Park, S. W., Chung, J. B., Song, S. Y., . . . Park, J. Y. (2013). Comparison of the sixth and seventh editions of the AJCC TNM classification for gallbladder cancer. J Gastrointest Surg, 17(5), 925-930. doi:10.1007/s11605-012-2134-9

Ono, S., Fumino, S., Shimadera, S., & Iwai, N. (2010). Long-term outcomes after hepaticojejunostomy for choledochal cyst: a 10- to 27-year follow-up. J Pediatr Surg, 45(2), 376-378. doi:10.1016/j.jpedsurg.2009.10.078

Ouchi, K., Mikuni, J., Kakugawa, Y., & Organizing Committee, T. t. A. C. o. t. J. S. o. B. S. (2002). Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg, 9(2), 256-260. doi:10.1007/s005340200028

Paik, W. H., Park, Y. S., Hwang, J. H., Lee, S. H., Yoon, C. J., Kang, S. G., . . . Yoon, Y. B. (2009). Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc, 69(1), 55-62. doi:10.1016/j.gie.2008.04.005

Pandey, M., Sood, B. P., Shukla, R. C., Aryya, N. C., Singh, S., & Shukla, V. K. (2000). Carcinoma of the gallbladder: role of sonography in diagnosis and staging. J Clin Ultrasound, 28(5), 227-232.

Park, J. Y., Hong, S. P., Kim, Y. J., Kim, H. J., Kim, H. M., Cho, J. H., . . . Bang, S. (2009). Long-term follow up of gallbladder polyps. J Gastroenterol Hepatol, 24(2), 219-222. doi:10.1111/j.1440-1746.2008.05689.x

Patel, T. (2011). Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol, 8(4), 189-200. doi:10.1038/nrgastro.2011.20

Patienters upplevelse av att leva med Perkutant Transhepatiskt Cholangiografi (PTC)-dränage och deras upplevelser av kontakten med sjukhusvården; C-uppsats av G. Olsson och C. Wallin, Uppsala universitet.

Penz, M., Kornek, G. V., Raderer, M., Ulrich-Pur, H., Fiebiger, W., Lenauer, A., . . . Scheithauer, W. (2001). Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol, 12(2), 183-186.

Pitman, M. B., Centeno, B. A., Ali, S. Z., Genevay, M., Stelow, E., Mino-Kenudson, M., . . . Papanicolaou Society of, C. (2014). Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol, 42(4), 338-350. doi:10.1002/dc.23092

Pitman, M. B., & Layfield, L. J. (2014). Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review. Cancer Cytopathol, 122(6), 399-411. doi:10.1002/cncy.21427

Polistina, F. A., Guglielmi, R., Baiocchi, C., Francescon, P., Scalchi, P., Febbraro, A., . . . Ambrosino, G. (2011). Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiother Oncol, 99(2), 120-123. doi:10.1016/j.radonc.2011.05.016

Prachayakul, V., Chaisayan, S., Aswakul, P., & Deesomsak, M. (2013). Clinical characteristics and treatment outcomes of patients with unresectable cholangiocarcinoma in Thailand: are there differences dependent on stent type? Asian Pac J Cancer Prev, 14(1), 529-532.

Pracht, M., Le Roux, G., Sulpice, L., Mesbah, H., Manfredi, S., Audrain, O., . . . Boucher, E. (2012). Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years. Chemotherapy, 58(2), 134-141. doi:10.1159/000337289

Prades, J., Remue, E., van Hoof, E., & Borras, J. M. (2015). Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy, 119(4), 464-474. doi:10.1016/j.healthpol.2014.09.006

Prasad, T. L., Kumar, A., Sikora, S. S., Saxena, R., & Kapoor, V. K. (2006). Mirizzi syndrome and gallbladder cancer. J Hepatobiliary Pancreat Surg, 13(4), 323-326. doi:10.1007/s00534-005-1072-2

Primrose, J. N., Fox, R., Palmer, D. H., Prasad, R., Mirza, D., Anthoney, D. A., . . . Bridgewater, J. A. (2017). Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study. Journal of Clinical Oncology, 35(15_suppl), 4006-4006. doi:10.1200/JCO.2017.35.15_suppl.4006

Raju, R. P., Jaganmohan, S. R., Ross, W. A., Davila, M. L., Javle, M., Raju, G. S., & Lee, J. H. (2011). Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis Sci, 56(5), 1557-1564. doi:10.1007/s10620-010-1550-5

Ramage, J. K., Donaghy, A., Farrant, J. M., Iorns, R., & Williams, R. (1995). Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology, 108(3), 865-869.

Ramirez-Merino, N., Aix, S. P., & Cortes-Funes, H. (2013). Chemotherapy for cholangiocarcinoma: An update. World J Gastrointest Oncol, 5(7), 171-176. doi:10.4251/wjgo.v5.i7.171

Randi, G., Malvezzi, M., Levi, F., Ferlay, J., Negri, E., Franceschi, S., & La Vecchia, C. (2009). Epidemiology of biliary tract cancers: an update. Ann Oncol, 20(1), 146-159. doi:10.1093/annonc/mdn533

Ratti, F., Cipriani, F., Ferla, F., Catena, M., Paganelli, M., & Aldrighetti, L. A. (2013). Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome. World J Surg, 37(6), 1388-1396. doi:10.1007/s00268-013-1980-2

Razumilava, N., & Gores, G. J. (2014). Cholangiocarcinoma. Lancet, 383(9935), 2168-2179. doi:10.1016/S0140-6736(13)61903-0

Razumilava, N., Gores, G. J., & Lindor, K. D. (2011). Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology, 54(5), 1842-1852. doi:10.1002/hep.24570

Rea, D. J., Heimbach, J. K., Rosen, C. B., Haddock, M. G., Alberts, S. R., Kremers, W. K., . . . Nagorney, D. M. (2005). Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg, 242(3), 451-458; discussion 458-461.

Reid, K. M., Ramos-De la Medina, A., & Donohue, J. H. (2007). Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg, 11(5), 671-681. doi:10.1007/s11605-006-0075-x

Reinhardt, M. J., Strunk, H., Gerhardt, T., Roedel, R., Jaeger, U., Bucerius, J., . . . Dumoulin, F. L. (2005). Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies. J Nucl Med, 46(7), 1158-1163.

Rerknimitr, R., Angsuwatcharakon, P., Ratanachu-ek, T., Khor, C. J., Ponnudurai, R., Moon, J. H., . . . Asia-Pacific Working Group on Hepatobiliary, C. (2013). Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol, 28(4), 593-607. doi:10.1111/jgh.12128

Ribero, D., Amisano, M., Lo Tesoriere, R., Rosso, S., Ferrero, A., & Capussotti, L. (2011). Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg, 254(5), 776-781; discussion 781-773. doi:10.1097/SLA.0b013e3182368f85

Rimola, J., Forner, A., Reig, M., Vilana, R., de Lope, C. R., Ayuso, C., & Bruix, J. (2009). Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology, 50(3), 791-798. doi:10.1002/hep.23071

Robles, R., Figueras, J., Turrion, V. S., Margarit, C., Moya, A., Varo, E., . . . Parrilla, P. (2004). Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg, 239(2), 265-271. doi:10.1097/01.sla.0000108702.45715.81

Robson, P. C., Heffernan, N., Gonen, M., Thornton, R., Brody, L. A., Holmes, R., . . . D'Angelica, M. (2010). Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol, 17(9), 2303-2311. doi:10.1245/s10434-010-1045-9

Rodriguez-Fernandez, A., Gomez-Rio, M., Medina-Benitez, A., Moral, J. V., Ramos-Font, C., Ramia-Angel, J. M., . . . Lardelli-Claret, P. (2006). Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol, 93(8), 650-664. doi:10.1002/jso.20533

Roskams, T. (2006). Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene, 25(27), 3818-3822. doi:10.1038/sj.onc.1209558

Rullier, A., Le Bail, B., Fawaz, R., Blanc, J. F., Saric, J., & Bioulac-Sage, P. (2000). Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol, 24(6), 870-876.

Ryan, J., & Faragher, I. (2014). Not all patients need to be discussed in a colorectal cancer MDT meeting. Colorectal Dis, 16(7), 520-526. doi:10.1111/codi.12581

Sai, J. K., Suyama, M., Kubokawa, Y., & Nobukawa, B. (2006). Gallbladder carcinoma associated with pancreatobiliary reflux. World J Gastroenterol, 12(40), 6527-6530.

Sakamoto, E., Nimura, Y., Hayakawa, N., Kamiya, J., Kondo, S., Nagino, M., . . . Uesaka, K. (1998). The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg, 227(3), 405-411.

Sangchan, A., Kongkasame, W., Pugkhem, A., Jenwitheesuk, K., & Mairiang, P. (2012). Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc, 76(1), 93-99. doi:10.1016/j.gie.2012.02.048

Sangfelt, P., Sundin, A., Wanders, A., Rasmussen, I., Karlson, B. M., Bergquist, A., & Rorsman, F. (2014). Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET. J Hepatol, 61(6), 1352-1357. doi:10.1016/j.jhep.2014.07.032

Sano, T., Shimada, K., Sakamoto, Y., Yamamoto, J., Yamasaki, S., & Kosuge, T. (2006). One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg, 244(2), 240-247. doi:10.1097/01.sla.0000217605.66519.38

Sasaki, E., Nagino, M., Ebata, T., Oda, K., Arai, T., Nishio, H., & Nimura, Y. (2006). Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg, 244(1), 99-105. doi:10.1097/01.sla.0000217675.22495.6f

Sasaki, R., Itabashi, H., Fujita, T., Takeda, Y., Hoshikawa, K., Takahashi, M., . . . Saito, K. (2006). Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer--from the perspective of mode of lymph node involvement and surgical outcome. World J Surg, 30(1), 36-42. doi:10.1007/s00268-005-0181-z

Schisler, R. E., Groninger, H., & Rosielle, D. A. (2012). Counseling patients on side effects and driving when starting opioids #248. J Palliat Med, 15(4), 484-485. doi:10.1089/jpm.2012.9596

Schultz, N. A., Larsen, P. N., Klarskov, B., Plum, L. M., Frederiksen, H. J., Christensen, B. M., . . . Hillingso, J. G. (2013). Evaluation of a fast-track programme for patients undergoing liver resection. Br J Surg, 100(1), 138-143. doi:10.1002/bjs.8996

Seehofer, D., Thelen, A., Neumann, U. P., Veltzke-Schlieker, W., Denecke, T., Kamphues, C., . . . Neuhaus, P. (2009). Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl, 15(11), 1499-1507. doi:10.1002/lt.21887

Selvaggi, S. M. (2004). Biliary brushing cytology. Cytopathology, 15(2), 74-79. doi:10.1111/j.1365-2303.2004.00133.x

Sempoux, C., Jibara, G., Ward, S. C., Fan, C., Qin, L., Roayaie, S., . . . Thung, S. N. (2011). Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis, 31(1), 49-60. doi:10.1055/s-0031-1272839

Sewnath, M. E., Karsten, T. M., Prins, M. H., Rauws, E. J., Obertop, H., & Gouma, D. J. (2002). A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg, 236(1), 17-27.

Shin, H. R., Oh, J. K., Masuyer, E., Curado, M. P., Bouvard, V., Fang, Y. Y., . . . Hong, S. T. (2010). Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci, 101(3), 579-585. doi:10.1111/j.1349-7006.2009.01458.x

Shin, S. R., Lee, J. K., Lee, K. H., Lee, K. T., Rhee, J. C., Jang, K. T., . . . Choi, D. W. (2009). Can the growth rate of a gallbladder polyp predict a neoplastic polyp? J Clin Gastroenterol, 43(9), 865-868. doi:10.1097/MCG.0b013e31819359aa

Shindoh, J., de Aretxabala, X., Aloia, T. A., Roa, J. C., Roa, I., Zimmitti, G., . . . Vauthey, J. N. (2015). Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg, 261(4), 733-739. doi:10.1097/SLA.0000000000000728

Singhal, D., van Gulik, T. M., & Gouma, D. J. (2005). Palliative management of hilar cholangiocarcinoma. Surg Oncol, 14(2), 59-74. doi:10.1016/j.suronc.2005.05.004

Siqueira, E., Schoen, R. E., Silverman, W., Martin, J., Rabinovitz, M., Weissfeld, J. L., . . . Slivka, A. (2002). Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc, 56(1), 40-47.

Soares, K. C., Arnaoutakis, D. J., Kamel, I., Rastegar, N., Anders, R., Maithel, S., & Pawlik, T. M. (2014). Choledochal cysts: presentation, clinical differentiation, and management. J Am Coll Surg, 219(6), 1167-1180. doi:10.1016/j.jamcollsurg.2014.04.023

Soares, K. C., Kamel, I., Cosgrove, D. P., Herman, J. M., & Pawlik, T. M. (2014). Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr, 3(1), 18-34. doi:10.3978/j.issn.2304-3881.2014.02.05

Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumor. Wiley-Blackwell; 2009. p. 256.

Soderlund, C., & Linder, S. (2006). Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc, 63(7), 986-995. doi:10.1016/j.gie.2005.11.052

Sofue, K., Arai, Y., Shimada, K., Takeuchi, Y., Kobayashi, T., Satake, M., & Sugimura, K. (2014). Right portal vein embolization with absolute ethanol in major hepatic resection for hepatobiliary malignancy. Br J Surg, 101(9), 1122-1128. doi:10.1002/bjs.9541

Sokolova, I. A., Halling, K. C., Jenkins, R. B., Burkhardt, H. M., Meyer, R. G., Seelig, S. A., & King, W. (2000). The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn, 2(3), 116-123. doi:10.1016/S1525-1578(10)60625-3

Somjaivong, B., Thanasilp, S., Preechawong, S., & Sloan, R. (2011). The influence of symptoms, social support, uncertainty, and coping on health-related quality of life among cholangiocarcinoma patients in northeast Thailand. Cancer Nurs, 34(6), 434-442. doi:10.1097/NCC.0b013e31820d0c3f

Song, H. K., Kim, M. H., Myung, S. J., Lee, S. K., Kim, H. J., Yoo, K. S., . . . Min, Y. I. (1999). Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone. Korean J Intern Med, 14(2), 1-8.

Speer, A. G., Cotton, P. B., Russell, R. C., Mason, R. R., Hatfield, A. R., Leung, J. W., . . . Lennon, C. A. (1987). Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet, 2(8550), 57-62.

Spelt, L., Ansari, D., Sturesson, C., Tingstedt, B., & Andersson, R. (2011). Fast-track programmes for hepatopancreatic resections: where do we stand? HPB (Oxford), 13(12), 833-838. doi:10.1111/j.1477-2574.2011.00391.x

Stain, S. C., Guthrie, C. R., Yellin, A. E., & Donovan, A. J. (1995). Choledochal cyst in the adult. Ann Surg, 222(2), 128-133.

Stein, D. E., Heron, D. E., Rosato, E. L., Anne, P. R., & Topham, A. K. (2005). Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol, 28(1), 21-23.

Sternby Eilard, M., Lundgren, L., Cahlin, C., Strandell, A., Svanberg, T., & Sandstrom, P. (2017). Surgical treatment for gallbladder cancer - a systematic literature review. Scand J Gastroenterol, 52(5), 505-514. doi:10.1080/00365521.2017.1284895

Stewart, C. J., Mills, P. R., Carter, R., O'Donohue, J., Fullarton, G., Imrie, C. W., & Murray, W. R. (2001). Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol, 54(6), 449-455.

Stiehl, A., Rudolph, G., Kloters-Plachky, P., Sauer, P., & Walker, S. (2002). Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol, 36(2), 151-156.

Strang p., Beck-Friis B., (red) Palliativ medicin och vård. 4 uppl. Stockholm : Liber . 2012.

Sudan, D., DeRoover, A., Chinnakotla, S., Fox, I., Shaw, B., Jr., McCashland, T., . . . Langnas, A. (2002). Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant, 2(8), 774-779.

Sugiyama, H., Tsuyuguchi, T., Sakai, Y., Ohtsuka, M., Miyazaki, M., & Yokosuka, O. (2012). Potential role of peroral cholangioscopy for preoperative diagnosis of cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech, 22(6), 532-536. doi:10.1097/SLE.0b013e3182686178

Suita, S., Shono, K., Kinugasa, Y., Kubota, M., & Matsuo, S. (1999). Influence of age on the presentation and outcome of choledochal cyst. J Pediatr Surg, 34(12), 1765-1768.

Sulpice, L., Rayar, M., Boucher, E., Pracht, M., Meunier, B., & Boudjema, K. (2012). Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg, 99(12), 1711-1717. doi:10.1002/bjs.8953

Sur, M. D., In, H., Sharpe, S. M., Baker, M. S., Weichselbaum, R. R., Talamonti, M. S., & Posner, M. C. (2015). Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol, 22(7), 2209-2217. doi:10.1245/s10434-014-4275-4

Tabata, M., Kawarada, Y., Yokoi, H., Higashiguchi, T., & Isaji, S. (2000). Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg, 7(2), 148-154. doi:10.1007/s005340000070148.534

Takahashi, Y., Nagino, M., Nishio, H., Ebata, T., Igami, T., & Nimura, Y. (2010). Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg, 97(12), 1860-1866. doi:10.1002/bjs.7228

Tanguturi, S. K., Wo, J. Y., Zhu, A. X., Dawson, L. A., & Hong, T. S. (2014). Radiation therapy for liver tumors: ready for inclusion in guidelines? Oncologist, 19(8), 868-879. doi:10.1634/theoncologist.2014-0097

Tarazov, P. G., Granov, D. A., Sergeev, V. I., Polikarpov, A. A., Polysalov, V. N., & Rozengauz, E. V. (2006). Preoperative portal vein embolization for liver malignancies. Hepatogastroenterology, 53(70), 566-570.

Tischendorf, J. J., Kruger, M., Trautwein, C., Duckstein, N., Schneider, A., Manns, M. P., & Meier, P. N. (2006). Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy, 38(7), 665-669. doi:10.1055/s-2006-925257

Todoroki, T., Okamura, T., Fukao, K., Nishimura, A., Otsu, H., Sato, H., & Iwasaki, Y. (1980). Gross appearance of carcinoma of the main hepatic duct and its prognosis. Surg Gynecol Obstet, 150(1), 33-40.

Tojima, Y., Nagino, M., Ebata, T., Uesaka, K., Kamiya, J., & Nimura, Y. (2003). Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg, 237(2), 201-207. doi:10.1097/01.SLA.0000048446.18118.FC

Trikudanathan, G., Navaneethan, U., Njei, B., Vargo, J. J., & Parsi, M. A. (2014). Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc, 79(5), 783-789. doi:10.1016/j.gie.2013.09.015

Tsai, M. S., Lin, W. H., Hsu, W. M., Lai, H. S., Lee, P. H., & Chen, W. J. (2008). Clinicopathological feature and surgical outcome of choledochal cyst in different age groups: the implication of surgical timing. J Gastrointest Surg, 12(12), 2191-2195. doi:10.1007/s11605-008-0593-9

Tsuda, M., Kurihara, N., Saito, H., Yamaki, T., Shimamura, H., Narushima, Y., . . . Takahashi, S. (2006). Ipsilateral percutaneous transhepatic portal vein embolization with gelatin sponge particles and coils in preparation for extended right hepatectomy for hilar cholangiocarcinoma. J Vasc Interv Radiol, 17(6), 989-994. doi:10.1097/01.RVI.0000223716.61444.e4

Turkmen, C., Ucar, A., Poyanli, A., Vatankulu, B., Ozkan, G., Basaran, M., . . . Adalet, I. (2013). Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease. Cancer Biother Radiopharm, 28(7), 534-540. doi:10.1089/cbr.2012.1455

Wahlin, S., & Tonnesen, H. (2014). [Time for "alcohol-free operations". Two standard drinks a day doubles the risk of postoperative complications]. Lakartidningen, 111(44-45), 1966-1969.

Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., . . . Investigators, A. B. C. T. (2010). Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med, 362(14), 1273-1281. doi:10.1056/NEJMoa0908721

Van Dyke, A. L., Langhamer, M. S., Zhu, B., Pfeiffer, R. M., Albanes, D., Andreotti, G., . . . Koshiol, J. (2018). Family History of Cancer and Risk of Biliary Tract Cancers: Results from the Biliary Tract Cancers Pooling Project. Cancer Epidemiol Biomarkers Prev, 27(3), 348-351. doi:10.1158/1055-9965.epi-17-1003

van Lienden, K. P., van den Esschert, J. W., de Graaf, W., Bipat, S., Lameris, J. S., van Gulik, T. M., & van Delden, O. M. (2013). Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol, 36(1), 25-34. doi:10.1007/s00270-012-0440-y

Wang, R. T., Xu, X. S., Liu, J., & Liu, C. (2012). Gallbladder carcinoma: analysis of prognostic factors in 132 cases. Asian Pac J Cancer Prev, 13(6), 2511-2514.

Wani, S., & Shah, R. J. (2013). Probe-based confocal laser endomicroscopy for the diagnosis of indeterminate biliary strictures. Curr Opin Gastroenterol, 29(3), 319-323. doi:10.1097/MOG.0b013e32835fee9f

Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003). The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 3, 25. doi:10.1186/1471-2288-3-25

Wiles, R., Thoeni, R. F., Barbu, S. T., Vashist, Y. K., Rafaelsen, S. R., Dewhurst, C., . . . Roberts, S. A. (2017). Management and follow-up of gallbladder polyps : Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). Eur Radiol, 27(9), 3856-3866. doi:10.1007/s00330-017-4742-y

Wiles, R., Varadpande, M., Muly, S., & Webb, J. (2014). Growth rate and malignant potential of small gallbladder polyps--systematic review of evidence. Surgeon, 12(4), 221-226. doi:10.1016/j.surge.2014.01.003

Williams, T. M., Majithia, L., Wang, S. J., & Thomas, C. R., Jr. (2014). Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer. Semin Radiat Oncol, 24(2), 94-104. doi:10.1016/j.semradonc.2014.01.001

Vitellas, K. M., Keogan, M. T., Freed, K. S., Enns, R. A., Spritzer, C. E., Baillie, J. M., & Nelson, R. C. (2000). Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiographics, 20(4), 959-975; quiz 1108-1109, 1112. doi:10.1148/radiographics.20.4.g00jl04959

Vogel, A., Wege, H., Caca, K., Nashan, B., & Neumann, U. (2014). The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int, 111(44), 748-754. doi:10.3238/arztebl.2014.0748

Vogl, T. J., Naguib, N. N., Nour-Eldin, N. E., Bechstein, W. O., Zeuzem, S., Trojan, J., & Gruber-Rouh, T. (2012). Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. Int J Cancer, 131(3), 733-740. doi:10.1002/ijc.26407

Wrighton, L. J., O'Bosky, K. R., Namm, J. P., & Senthil, M. (2012). Postoperative management after hepatic resection. J Gastrointest Oncol, 3(1), 41-47. doi:10.3978/j.issn.2078-6891.2012.003

Xiao, W. D., Peng, C. H., Zhou, G. W., Wu, W. D., Shen, B. Y., Yan, J. Q., . . . Li, H. W. (2005). Surgical treatment for Nevin stage IV and V gallbladder carcinoma: report of 70 cases. Hepatobiliary Pancreat Dis Int, 4(4), 589-592.

Yachimski, P., & Pratt, D. S. (2008). Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol, 42(2), 178-190. doi:10.1097/MCG.0b013e31806daf89

Yamaguchi, R., Nagino, M., Oda, K., Kamiya, J., Uesaka, K., & Nimura, Y. (2002). Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg, 89(9), 1130-1136. doi:10.1046/j.1365-2168.2002.02184.x

Yamamoto, S., Kubo, S., Hai, S., Uenishi, T., Yamamoto, T., Shuto, T., . . . Tanaka, T. (2004). Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci, 95(7), 592-595.

Yamasaki, S. (2003). Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg, 10(4), 288-291. doi:10.1007/s00534-002-0732-8

Yang, R., Wang, B., Chen, Y. J., Li, H. B., Hu, J. B., & Zou, S. Q. (2013). Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis. Anticancer Drugs, 24(8), 871-877. doi:10.1097/CAD.0b013e3283637292

Yi, B., Xu, A. M., Lai, E. C., Qu, Z. Q., Cheng, Q. B., Liu, C., . . . Jiang, X. Q. (2010). Preoperative portal vein embolization for hilar cholangiocarcinoma--a comparative study. Hepatogastroenterology, 57(104), 1341-1346.

Yildirim, E., Celen, O., Gulben, K., & Berberoglu, U. (2005). The surgical management of incidental gallbladder carcinoma. Eur J Surg Oncol, 31(1), 45-52. doi:10.1016/j.ejso.2004.09.006

Yokomizo, H., Yamane, T., Hirata, T., Hifumi, M., Kawaguchi, T., & Fukuda, S. (2007). Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Ann Surg Oncol, 14(4), 1366-1373. doi:10.1245/s10434-006-9219-1

Yoshimitsu, K., Honda, H., Shinozaki, K., Aibe, H., Kuroiwa, T., Irie, H., . . . Masuda, K. (2002). Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR Am J Roentgenol, 179(2), 423-428. doi:10.2214/ajr.179.2.1790423

You, D. D., Lee, H. G., Paik, K. Y., Heo, J. S., Choi, S. H., & Choi, D. W. (2008). What is an adequate extent of resection for T1 gallbladder cancers? Ann Surg, 247(5), 835-838. doi:10.1097/SLA.0b013e3181675842

Yu, F. X., Ji, S. Q., Su, L. F., Zhang, S. C., & Zhang, Q. Y. (2013). Effectiveness and safety of preoperative percutaneous transhepatic cholangiodrainage with bile re-infusion in patients with hilar cholangiocarcinoma: a retrospective controlled study. Am J Med Sci, 346(5), 353-357. doi:10.1097/MAJ.0b013e3182755de6

Zeng, Z. C., Tang, Z. Y., Fan, J., Zhou, J., Qin, L. X., Ye, S. L., . . . Tan, Y. S. (2006). Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients. Cancer J, 12(2), 113-122.

Zervos, E. E., Osborne, D., Goldin, S. B., Villadolid, D. V., Thometz, D. P., Durkin, A., . . . Rosemurgy, A. S. (2005). Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg, 190(5), 810-815. doi:10.1016/j.amjsurg.2005.07.025

Zhang, W. J., Xu, G. F., Tian, Z. Q., Wu, G. Z., Wang, H., & Guan, W. X. (2015). Surgical approach does not influence the outcome of incidental gallbladder carcinoma. Int J Clin Exp Med, 8(1), 869-875.